OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study
Maria Papaleontiou, Debbie Chen, Mousumi Banerjee, et al.
Thyroid (2021) Vol. 31, Iss. 9, pp. 1383-1390
Open Access | Times Cited: 34
Maria Papaleontiou, Debbie Chen, Mousumi Banerjee, et al.
Thyroid (2021) Vol. 31, Iss. 9, pp. 1383-1390
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis
Timothy M. Ullmann, Maria Papaleontiou, Julie Ann Sosa
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 2, pp. 271-280
Open Access | Times Cited: 47
Timothy M. Ullmann, Maria Papaleontiou, Julie Ann Sosa
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 2, pp. 271-280
Open Access | Times Cited: 47
Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Eu Jeong Ku, Won Sang Yoo, Eun Kyung Lee, et al.
The Journal of Clinical Endocrinology & Metabolism (2021)
Open Access | Times Cited: 41
Eu Jeong Ku, Won Sang Yoo, Eun Kyung Lee, et al.
The Journal of Clinical Endocrinology & Metabolism (2021)
Open Access | Times Cited: 41
Progress and Challenges in Thyroid Cancer Management
Megan R. Haymart
Endocrine Practice (2021) Vol. 27, Iss. 12, pp. 1260-1263
Closed Access | Times Cited: 40
Megan R. Haymart
Endocrine Practice (2021) Vol. 27, Iss. 12, pp. 1260-1263
Closed Access | Times Cited: 40
Construction and validation of nomograms to predict central lymph node metastasis in clinical node-negative unilateral papillary thyroid carcinoma
Longqing Hu, Bei Qian, Junlin Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Longqing Hu, Bei Qian, Junlin Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ultrasonic radiomics in predicting pathologic type for thyroid cancer: a preliminary study using radiomics features for predicting medullary thyroid carcinoma
Dai Zhang, Fan Yang, Wenjing Hou, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Dai Zhang, Fan Yang, Wenjing Hou, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Effects of vitamin D3 and calcium supplementation on bone of young adults after thyroidectomy of differentiated thyroid carcinoma
Lei Sun, Xiaoyun Lin, Naishi Li, et al.
Endocrine (2025)
Open Access
Lei Sun, Xiaoyun Lin, Naishi Li, et al.
Endocrine (2025)
Open Access
METTL3-mediated m6A modification of MT1G inhibits papillary thyroid carcinoma cell growth and metastasis via Wnt/β-catenin pathway
Jie Liu, Lei Yao, Yating Chen, et al.
Tissue and Cell (2025) Vol. 95, pp. 102902-102902
Closed Access
Jie Liu, Lei Yao, Yating Chen, et al.
Tissue and Cell (2025) Vol. 95, pp. 102902-102902
Closed Access
Tailoring TSH suppression in differentiated thyroid carcinoma: evidence, controversies, and future directions
Xinxin Song, Xin Zhi, Linxue Qian
Endocrine (2025)
Closed Access
Xinxin Song, Xin Zhi, Linxue Qian
Endocrine (2025)
Closed Access
Identification of Risk Factors for Cause-specific Mortality in Advanced Papillary Thyroid Cancer and Construction of a Competing Risk Model: A SEER-Based Study
Yunyi Yang, Xiaoli He, Xiaoxiao Qu, et al.
Cancer Control (2025) Vol. 32
Open Access
Yunyi Yang, Xiaoli He, Xiaoxiao Qu, et al.
Cancer Control (2025) Vol. 32
Open Access
Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy
Benjamin J. Gigliotti, Sina Jasim
Endocrine (2023) Vol. 83, Iss. 2, pp. 251-258
Closed Access | Times Cited: 10
Benjamin J. Gigliotti, Sina Jasim
Endocrine (2023) Vol. 83, Iss. 2, pp. 251-258
Closed Access | Times Cited: 10
Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: Involvement of PI3K/AKT/mTOR signaling pathway
LiangDong Chen, Deqiang Zhuo, Hongyin Yuan
Immunology Letters (2022) Vol. 246, pp. 10-17
Closed Access | Times Cited: 15
LiangDong Chen, Deqiang Zhuo, Hongyin Yuan
Immunology Letters (2022) Vol. 246, pp. 10-17
Closed Access | Times Cited: 15
Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention
Rongqian Wu, Junping Zhang, Guilin Zou, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 809-823
Open Access | Times Cited: 2
Rongqian Wu, Junping Zhang, Guilin Zou, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 809-823
Open Access | Times Cited: 2
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2024
Mijin Kim, Ji-In Bang, Ho‐Cheol Kang, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 115-146
Open Access | Times Cited: 2
Mijin Kim, Ji-In Bang, Ho‐Cheol Kang, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 115-146
Open Access | Times Cited: 2
Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis
Ho-Ryun Won, Eon Ju Jeon, Jae Won Chang, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1470-1470
Open Access | Times Cited: 11
Ho-Ryun Won, Eon Ju Jeon, Jae Won Chang, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1470-1470
Open Access | Times Cited: 11
Towards De-Implementation of low-value thyroid care in older adults
Jennifer M. Perkins, Maria Papaleontiou
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 29, Iss. 5, pp. 483-491
Open Access | Times Cited: 8
Jennifer M. Perkins, Maria Papaleontiou
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 29, Iss. 5, pp. 483-491
Open Access | Times Cited: 8
Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
Bin Xu, Shuyan Gu, Zhou Ningming, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Bin Xu, Shuyan Gu, Zhou Ningming, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
The Relationship between Thyrotropin Serum Concentrations and Thyroid Carcinoma
Xueqi Zhang, Lijun Tian, Di Teng, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5017-5017
Open Access | Times Cited: 4
Xueqi Zhang, Lijun Tian, Di Teng, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5017-5017
Open Access | Times Cited: 4
An age-and sex-matched postoperative therapy should be required in thyroid papillary carcinoma
Caigu Yan, Jinjin Sun, Xianghui He, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Caigu Yan, Jinjin Sun, Xianghui He, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data
X M Shi, Haitao Tang, Tingting Zhang, et al.
EClinicalMedicine (2024) Vol. 77, pp. 102912-102912
Open Access | Times Cited: 1
X M Shi, Haitao Tang, Tingting Zhang, et al.
EClinicalMedicine (2024) Vol. 77, pp. 102912-102912
Open Access | Times Cited: 1
HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway
Dong Wang, Xiaoqian Liu, Meijing Li, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 2, pp. 238-252
Closed Access | Times Cited: 2
Dong Wang, Xiaoqian Liu, Meijing Li, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 2, pp. 238-252
Closed Access | Times Cited: 2
Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer
Ilaria Stramazzo, Silvia Capriello, Alessandro Antonelli, et al.
HORMONES (2022) Vol. 21, Iss. 4, pp. 537-543
Open Access | Times Cited: 4
Ilaria Stramazzo, Silvia Capriello, Alessandro Antonelli, et al.
HORMONES (2022) Vol. 21, Iss. 4, pp. 537-543
Open Access | Times Cited: 4
Evolution of suppressing TSH therapy at diagnosis and in the long-term follow-up in a cohort of differentiated thyroid cancer
Gonzalo Díaz-Soto, Pablo Fernández, Beatriz Torres, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2022) Vol. 69, Iss. 10, pp. 844-851
Closed Access | Times Cited: 4
Gonzalo Díaz-Soto, Pablo Fernández, Beatriz Torres, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2022) Vol. 69, Iss. 10, pp. 844-851
Closed Access | Times Cited: 4
Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok
Yotsapon Thewjitcharoen, Waralee Chatchomchuan, Ekgaluck Wanothayaroj, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38290-e38290
Open Access
Yotsapon Thewjitcharoen, Waralee Chatchomchuan, Ekgaluck Wanothayaroj, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38290-e38290
Open Access
Analysis of Clinical Factors Related to Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
中音 方
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 990-999
Closed Access
中音 方
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 990-999
Closed Access
Prognostic Implications of Maintaining the Target Thyroid-Stimulating Hormone Status Based on the 2015 American Thyroid Association Guidelines in Patients with Low-Risk Papillary Thyroid Carcinoma after Lobectomy: A 5-Year Landmark Analysis
Ye Won Jeon, Young Jin Suh, Seung Taek Lim
Cancers (2024) Vol. 16, Iss. 19, pp. 3253-3253
Open Access
Ye Won Jeon, Young Jin Suh, Seung Taek Lim
Cancers (2024) Vol. 16, Iss. 19, pp. 3253-3253
Open Access
